Pasithea Therapeutics Announces Positive Safety Review Committee (SRC) Recommendation from its ongoing Phase 1 Clinical Trial of PAS-004 in Advanced Cancer
-- SRC recommended that the trial escalate to the next dose level…
NewAmsterdam Pharma Announces Positive Topline Data from Pivotal Phase 3 TANDEM Clinical Trial Evaluating the Fixed-Dose Combination of Obicetrapib 10 mg and Ezetimibe 10 mg in Patients with ASCVD or ASCVD Risk Factors and/or HeFH
-- Achieved all co-primary endpoints of LS mean reduction in LDL-C on…
Quantinuum together with Mitsui advance unforgeable quantum tokens over fibre network in first ever trial
First successful delivery of quantum tokens using commercial QKD hardware, demonstrating fast transaction…
Quantinuum together with Mitsui advance unforgeable quantum tokens over fibre network in first ever trial
First successful delivery of quantum tokens using commercial QKD hardware, demonstrating fast transaction…
Quantinuum together with Mitsui advance unforgeable quantum tokens over fibre network in first ever trial
First successful delivery of quantum tokens using commercial QKD hardware, demonstrating fast transaction…
Quantinuum together with Mitsui advance unforgeable quantum tokens over fibre network in first ever trial
First successful delivery of quantum tokens using commercial QKD hardware, demonstrating fast transaction…
Protara Therapeutics to Present New Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC at the 25th Annual Meeting of the Society of Urologic Oncology
November 15, 2024 17:52 ET | Source: Protara Therapeutics NEW YORK, Nov.…
Replimune Presents Late-Breaking Abstract Featuring Data from IGNYTE Clinical Trial of RP1 Combined with Nivolumab in Anti-PD1 Failed Melanoma at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC 2024)
November 09, 2024 13:00 ET | Source: Replimune Group Inc Oral presentation…